Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

6 Mar 2024 14:30

RNS Number : 8693F
Indivior PLC
06 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on March 5, 2024, Mark Crossley, Chief Executive Officer and a PDMR, received 91,204 ordinary shares in the Company of $0.50 each ('Shares').

This arose as a result of the release of awards granted on March 5, 2019 and August 8, 2019 under the Indivior Long-Term Incentive Plan, which vested in respect of a total of 159,311 Shares on March 5, 2021 and which were then subject to a two-year post-vesting holding period. Following the end of the holding period, the Shares were released on March 5, 2024 on a net settled basis, resulting in the delivery of 91,204 Shares.

Following this transaction, Mark Crossley has a beneficial interest in 181,236 Shares in the Company.

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Mark Crossley

2

 

Reason for the notification

 

a)

 

Position/status

  

Director / PDMR - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Indivior PLC

b)

 

LEI

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Release of Shares following the end of the two-year holding period after vesting of an award granted under the Indivior Long-Term Incentive Plan.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

N/A

91,204

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

N/A

e)

 

Date of the transaction

March 5, 2024

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUPGWUPCGCQ
Date   Source Headline
28th Feb 20184:53 pmRNSHolding(s) in Company
19th Feb 20187:00 amRNSHolding(s) in Company
15th Feb 20187:00 amRNSFinal Results
14th Feb 20189:50 amRNSHolding(s) in Company
12th Feb 20183:49 pmRNSHolding(s) in Company
8th Feb 20183:27 pmRNSHolding(s) in Company
8th Feb 20187:00 amRNSIndivior asserts new patent against ANDA-filers
6th Feb 20182:14 pmRNSHolding(s) in Company
1st Feb 20187:05 amRNSTotal Voting Rights
1st Feb 20187:00 amRNSIndivior Provides Update on Tax Position
19th Jan 20187:00 amRNSNotice of Results
8th Jan 20189:24 amRNSHolding(s) in Company
4th Jan 20181:00 pmRNSJ.P. Morgan Healthcare Conference
3rd Jan 20187:00 amRNSIndivior and Addex Enter Strategic Collaboration
19th Dec 20177:00 amRNSIndivior amends and extends $534m debt facilities
12th Dec 20177:00 amRNSIndivior's RBP-7000 NDA Accepted by FDA
8th Dec 20177:00 amRNSAdditional Listing
1st Dec 20177:00 amRNSFDA Approves SUBLOCADE (TM)
23rd Nov 20171:46 pmRNSHolding(s) in Company
10th Nov 20174:02 pmRNSBlock listing Interim Review
6th Nov 20177:00 amRNSJefferies London Healthcare Conference
2nd Nov 20171:28 pmRNSBoard Committee Changes
2nd Nov 201711:40 amRNSHolding(s) in Company
2nd Nov 201711:00 amRNS3rd Quarter Results
1st Nov 20177:00 amRNSFDA Advisory Committees Vote to Approve RBP-6000
10th Oct 20177:00 amRNSNotice of Results
9th Oct 20171:17 pmRNSHolding(s) in Company
3rd Oct 20174:00 pmRNSFDA Posts Advisory Committee Notice for RBP-6000
2nd Oct 20177:00 amRNSRBP-7000 - Submission of NDA to U.S. FDA
25th Sep 20177:00 amRNSIndivior settlement with Mylan Pharmaceuticals
21st Sep 20173:36 pmRNSHolding(s) in Company
21st Sep 20179:37 amRNSHolding(s) in Company
15th Sep 20177:00 amRNSIndivior asserts new patent against ANDA-filers
11th Sep 20179:50 amRNSHolding(s) in Company
1st Sep 20173:04 pmRNSTotal Voting Rights
1st Sep 20177:00 amRNSIndivior to appeal court rulings ANDA litigation
31st Aug 20175:21 pmRNSHolding(s) in Company
30th Aug 20175:00 pmRNSMorgan Stanley Annual Global Healthcare Conference
14th Aug 20177:00 amRNSHolding(s) in Company
10th Aug 20174:36 pmRNSDirector/PDMR Shareholding (Replacement)
10th Aug 20174:00 pmRNSDirector/PDMR Shareholding
8th Aug 201711:24 amRNSHolding(s) in Company
8th Aug 201711:16 amRNSHolding(s) in Company
8th Aug 201711:14 amRNSHolding(s) in Company
8th Aug 201711:10 amRNSHolding(s) in Company
2nd Aug 201711:08 amRNSHolding(s) in Company
1st Aug 20177:00 amRNSTotal Voting Rights
31st Jul 20173:58 pmRNSHolding(s) in Company
31st Jul 20177:30 amRNSIndivior's NALSCUE® Receives ANSM MA for France
31st Jul 20177:00 amRNSRBP-6000 NDA Receives FDA Priority Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.